e-Dialog, Inc.

British Airways Selects e-Dialog as Preferred E-mail Communications Provider

British Airways Selects e-Dialog as Preferred E-mail Communications Provider

March 1, 2006

LONDON & LEXINGTON, Mass.--(BUSINESS WIRE)--March 1, 2006--British Airways has completed a competitive tender process and appointed e-Dialog as its e-mail marketing service provider for customer communications in the UK.

e-Dialog will provide British Airways with strategic and technological expertise and support for its e-mail communications to Executive Club members and registered customers on its Web site, www.ba.com.

TransMedics, Inc.

TransMedics, Inc., Makers of the First Device to Maintain Functioning Organs Outside the Body, Raises $29.75 Million in Series C Funding Led by 3i

TransMedics, Inc., Makers of the First Device to Maintain Functioning Organs Outside the Body, Raises $29.75 Million in Series C Funding Led by 3i

March 14, 2006

ANDOVER, Mass.--(BUSINESS WIRE)--March 14, 2006--TransMedics, Inc., a privately held medical device company founded in 1998 to address the unmet need for better, more effective organ transplant technologies, announced today that it has raised $29.75 million in Series C financing. The company's breakthrough, investigational technology, the Organ Care System, is the first organ transport system designed to maintain organs in a warm, functioning state outside of the body to optimize their health, enabling living organ transplant.

Morphotek, Inc.

Morphotek Announces Appointments and Promotions To Management Team

Morphotek Announces Appointments and Promotions To Management Team

March 13, 2006

Exton, PA, March 13, 2006 -- Morphotek®, Inc. announced today the appointment of Robert Radie as Chief Business Officer and the promotion of Dr. Luigi Grasso to Senior Vice President of Research & Development. These advancements are at a time that the company moves forward with its broad therapeutic antibody pipeline through clinical trials and continues to market its human antibody platform technology to support internal product development and collaborative alliances.

Helicos BioSciences Corporation

Helicos BioSciences Announces $40 Million Funding Round

Helicos BioSciences Announces $40 Million Funding Round

March 15, 2006

Pioneer in High-Speed, High-Sensitivity Sequencing Receives Major Investment from Top-Tier Venture Capital Firms in Support of "true Single Molecule Sequencing" (tSMS(TM)) Technologies and Techniques

Interactive Supercomputing Corporation

Star-P named “Most Significant New High Performance Computing Software”

Star-P named “Most Significant New High Performance Computing Software”

November 14, 2006

Wins HPCwire’s 2006 Editors’ Choice Award

TAMPA, Fla., Nov. 14, 2006 – Interactive Supercomputing’s (ISC) Star-P™ software won the HPCwire 2006 Editors’ Choice Award for Most Significant New HPC Software Product. The award, announced yesterday at the SC06 international conference, is widely recognized as the most prestigious in the technical computing industry.

Zalicus

CombinatoRx Announces Closing of $48.0 Million Private Placement

CombinatoRx Announces Closing of $48.0 Million Private Placement

March 24, 2006

BOSTON--(BUSINESS WIRE)--March 24, 2006--CombinatoRx, Incorporated (NASDAQ: CRXX - News), today announced that it has closed the previously announced private placement of approximately 4.68 million shares of common stock at a price of $10.25 per share for a total purchase price of $48.0 million. Cowen & Co. LLC served as exclusive placement agent for the transaction. Pacific Growth Equities, LLC acted as financial advisor.

VisEn Medical, Inc.

VisEn Medical Introduces NanoSPARKS(TM) Line of Optical Imaging Probes

VisEn Medical Introduces NanoSPARKS(TM) Line of Optical Imaging Probes

March 27, 2006

ORLANDO, Fla.--(BUSINESS WIRE)--March 27, 2006--VisEn Medical, a leader in optical imaging technologies for biomedical research, today announced the introduction of the first three products in a new line of optical imaging probes. Called NanoSPARKS(TM), the new product line uses super-bright, targetable, biocompatible nanoparticles for imaging of biological and molecular processes in vivo.

BG Medicine, Inc.

BG Medicine to Conduct Joint Biomarker Discovery Study for Muscle Toxicity with Mitsubishi Pharma Corporation

BG Medicine to Conduct Joint Biomarker Discovery Study for Muscle Toxicity with Mitsubishi Pharma Corporation

March 28, 2006

Waltham, MA -- March 28, 2006 -- BG Medicine Inc. today announced a collaborative preclinical research study into the biochemical origins of muscle toxicity and associated biomarkers with Mitsubishi Pharma Corporation (Osaka, Japan).

Ensemble Therapeutics Corporation

Ensemble Discovery Corporation Appoints Laurence Reid Chief Business Officer

Ensemble Discovery Corporation Appoints Laurence Reid Chief Business Officer

March 28, 2006

Cambridge, MA (March 28, 2006) - Ensemble Discovery Corporation today announced the appointment of Laurence E. Reid, Ph.D. as Chief Business Officer. In this position, Dr. Reid will lead strategic business planning and corporate development activities for the Company. He will work closely with the other members of Ensemble’s executive team to align business strategies and research and development efforts.

Affinnova, Inc.

Affinnova Awarded Broad Patent for Interactive Product Design Technology

Affinnova Awarded Broad Patent for Interactive Product Design Technology

March 29, 2006

Breakthrough technology empowers marketers to harness consumer input in the development of innovative products